Updates matching "Tobacco Regulation and Products"

San Diego, Calif . – Starting this week, on July 14, tobacco retailers in San Diego County will start paying a licensing fee that will fund and ensure strong enforcement of the tobacco retail license ordinance that took effect in July 2021. The measure requires annual permits, as well as

Today the U.S. Food and Drug Administration (FDA) announced it will issue marketing denial orders to all JUUL e-cigarette products.

Today the Biden Administration announced its intention for the U.S. Food and Drug Administration (FDA) to put forth a proposed rule to set a maximum level of nicotine in cigarettes and certain tobacco products to an amount that would reduce addiction.

San Diego County voted for a budget that supports the county’s tobacco retailer licensing ordinance passed in early 2020. This budget provides for strong enforcement including annual monitoring, fines, license suspension and revocation for non-compliant retailers.

WASHINGTON, DC - On Tuesday, May 24, the DC Council passed the FY23 Budget with funding for the Flavored Tobacco Product Prohibition Amendment Act of 2021 ending the sale of flavored tobacco products in the District of Columbia. Funding this law will protect DC kids from Big Tobacco, advance

In yet another delay that leaves America’s kids at risk, the FDA has told a federal court that it won’t finish its review of marketing applications for the most popular e-cigarette products until June 2023 – nearly two years after the September 9, 2021, court-ordered deadline to do so.

The U.S. Food and Drug Administration (FDA) released its proposed rules today to eliminate menthol cigarettes and eliminate all flavors in all cigars.

Tobacco use rates among US adults hit an all-time low, but rates remain high among certain populations according to data released by the Centers for Disease Control and Prevention today.

American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Arizona rallied at the State Capitol Monday to urge lawmakers to pass legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing is critical in accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients.